GLP-1 agonists , or glucagon-like peptide-1 substances, are representing as a remarkable advance in managing diabetes mellitus . These novel therapies work by boosting insulin release and inhibiting https://glp-1627405.blognody.com/51492056/glp-1-a-promising-approach-in-diabetes-management